COMPANY INFO
Miist Therapeutics is a private pharmaceutical company founded in 2019 by Dalton Signor. It is headquartered in Alameda, CA, with about 5 employees. The company develops inhaled therapies designed to provide rapid symptom relief, particularly for smoking cessation and migraine relief, using clinically validated aerosol physics technology. Its website is https://www.miisttherapeutics.com/. (PitchBook, Tracxn)
MiistMed is an innovative pharmaceutical company specializing in inhaled therapies for rapid symptom relief, such as smoking cessation and migraine relief. Founded in 2019 and based in Alameda, California, MiistMed uses clinically validated aerosol physics technology to develop safer and more effective pharmaceutical solutions.
The MiistMed leadership team is composed of experienced pharmaceutical executives, scientists, and industry veterans who collectively drive the company's growth, innovation, and scientific rigor. Their combined expertise in clinical development, regulatory processes, research, and technological innovation positions MiistMed to push the boundaries in inhaled therapeutics. The company’s management team demonstrates cohesive leadership, blending entrepreneurial spirit with deep domain expertise to effectively execute MiistMed’s ambitious mission.
Dalton Signor serves as the CEO of MiistMed, where he is actively leading the charge on building the company and executing its vision to revolutionize inhaled pharmaceutical therapies. Dalton has driven MiistMed’s strategic vision since its founding, leading the company through multiple funding rounds and focusing on rapid development of therapies for smoking cessation and migraine relief.
Dalton’s background includes founding MiistMed and overseeing its growth from the ground up. Based in the San Francisco Bay Area, he is recognized as both CEO and founder, establishing himself as the cornerstone of MiistMed’s leadership team and setting the tone for the company’s innovative approach to healthcare.
Dougal Thring heads all clinical, preclinical, and regulatory activities at MiistMed, ensuring excellence in clinical trial design and regulatory submissions for the company’s product pipeline. His leadership in clinical strategy is pivotal for MiistMed’s advancement through key clinical milestones, underpinning the company’s reputation for scientific rigor and compliance.
Dougal holds a Master of Pharmaceutical Medicine from UNSW Australia and an MBA from the University of Adelaide. His industry expertise spans early phase clinical trials and pharmaceutical development, having previously served as COO at NeuroScientific Biopharmaceuticals and held leadership roles across clinical development and operational functions.
Eric Ezerins leads research and development at MiistMed, focusing on the company’s proprietary inhaled nicotine delivery system designed for FDA approval. His work is central to developing a water-based nicotine device that targets effective smoking cessation while minimizing health effects—one of MiistMed’s signature innovations.
Eric earned his Bachelor’s degree in Bioengineering and Biomedical Engineering from Northeastern University. He has served as Research Development Process Engineer at Ocular Therapeutix and Project Manager at Alexion Pharmaceuticals, bringing significant R&D and product management expertise to MiistMed’s leadership team.
Thor Wilbanks manages special projects at MiistMed, utilizing his deep knowledge of physics and advanced technology to support innovation and optimize product development. Thor’s work directly impacts MiistMed’s ability to translate breakthrough science into operational and commercial success.
Thor earned a PhD in Physics from the University of California, Berkeley, and an AB in Physics from Harvard University. With decades of experience across research, operations, and technology, including specialized work in aerosol technology and laser machining, Thor enriches the MiistMed executive team with broad technical and scientific leadership.
The MiistMed leadership team brings together executive experience spanning founding, scientific innovation, clinical development, and operational excellence. This diverse management structure enables the company to maintain a strong vision, foster rapid innovation, and execute on both science and business objectives. As MiistMed continues to expand, the collaborative approach of its management team will be crucial in realizing its mission and scaling its impact in the pharmaceutical industry.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the MiistMed leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.